-
Mashup Score: 0
After ORBITA-COSMIC, Reducer device’s mechanism of benefit remains unknown
Source: www.medpagetoday.comCategories: General Medicine News, Cardiology News and JournTweet
After ORBITA-COSMIC, Reducer device’s mechanism of benefit remains unknown
A study presented at #ACC24 found that a CSR implant lead to symptom relief for people with stable #cvCAD & refractory angina. Learn more about the ORBITA-COSMIC trial in @medpagetoday: https://t.co/ZoYGLQPalj @nicolejlou